Literature DB >> 26474995

Why is Acinetobacter baumannii a problem for critically ill patients?

Marin H Kollef, Michael S Niederman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26474995     DOI： 10.1007/s00134-015-4096-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity.

Authors:  Yun Kyung Chung; Jae-Seok Kim; Seung Soon Lee; Jeong-A Lee; Han-Sung Kim; Kyong-Sok Shin; Eun Young Park; Bog Soun Kang; Hee Jung Lee; Hyun Joo Kang
Journal:  Am J Infect Control       Date:  2015-08-18       Impact factor: 2.918

2.  Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay.

Authors:  Andrew F Shorr; Scott T Micek; Emily C Welch; Joshua A Doherty; Richard M Reichley; Marin H Kollef
Journal:  Crit Care Med       Date:  2011-01       Impact factor: 7.598

3.  De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.

Authors:  J Garnacho-Montero; A Gutiérrez-Pizarraya; A Escoresca-Ortega; Y Corcia-Palomo; Esperanza Fernández-Delgado; I Herrera-Melero; C Ortiz-Leyba; J A Márquez-Vácaro
Journal:  Intensive Care Med       Date:  2013-09-12       Impact factor: 17.440

4.  Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study.

Authors:  Marya D Zilberberg; Marin H Kollef; Andrew F Shorr
Journal:  J Hosp Med       Date:  2015-09-09       Impact factor: 2.960

5.  Time to Appropriate Antibiotic Therapy Is an Independent Determinant of Postinfection ICU and Hospital Lengths of Stay in Patients With Sepsis.

Authors:  David Zhang; Scott T Micek; Marin H Kollef
Journal:  Crit Care Med       Date:  2015-10       Impact factor: 7.598

6.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

7.  International study of the prevalence and outcomes of infection in intensive care units.

Authors:  Jean-Louis Vincent; Jordi Rello; John Marshall; Eliezer Silva; Antonio Anzueto; Claude D Martin; Rui Moreno; Jeffrey Lipman; Charles Gomersall; Yasser Sakr; Konrad Reinhart
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

8.  Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

Authors:  Jose Garnacho-Montero; Jose Luis Garcia-Garmendia; Ana Barrero-Almodovar; Francisco J Jimenez-Jimenez; Carmen Perez-Paredes; Carlos Ortiz-Leyba
Journal:  Crit Care Med       Date:  2003-12       Impact factor: 7.598

Review 9.  New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections.

Authors:  Matteo Bassetti; Elda Righi
Journal:  Curr Opin Crit Care       Date:  2015-10       Impact factor: 3.687

10.  Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections.

Authors:  A Batirel; I I Balkan; O Karabay; C Agalar; S Akalin; O Alici; E Alp; F A Altay; N Altin; F Arslan; T Aslan; N Bekiroglu; S Cesur; A D Celik; M Dogan; B Durdu; F Duygu; A Engin; D O Engin; I Gonen; E Guclu; T Guven; C A Hatipoglu; S Hosoglu; M K Karahocagil; A U Kilic; B Ormen; D Ozdemir; S Ozer; N Oztoprak; N Sezak; V Turhan; N Turker; H Yilmaz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-15       Impact factor: 3.267
View more
  3 in total

Review 1.  Preventing Transmission of Multidrug-Resistant Pathogens in the Intensive Care Unit.

Authors:  Jeffrey R Strich; Tara N Palmore
Journal:  Infect Dis Clin North Am       Date:  2017-07-05       Impact factor: 5.982

2.  Combined Effects Of Low Incubation Temperature, Minimal Growth Medium, And Low Hydrodynamics Optimize Acinetobacter baumannii Biofilm Formation.

Authors:  Emmanuel C Eze; Mohamed E El Zowalaty
Journal:  Infect Drug Resist       Date:  2019-11-15       Impact factor: 4.003

3.  Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives.

Authors:  Davide Fiore Bavaro; Alessandra Belati; Lucia Diella; Monica Stufano; Federica Romanelli; Luca Scalone; Stefania Stolfa; Luigi Ronga; Leonarda Maurmo; Maria Dell'Aera; Adriana Mosca; Lidia Dalfino; Salvatore Grasso; Annalisa Saracino
Journal:  Antibiotics (Basel)       Date:  2021-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.